The mortality rate for liver malignant neoplasms in Japan, forecasted from 2024 to 2028, shows a consistent decrease from 19.0 to 18.4 deaths per hundred thousand persons. Observing year-on-year variations, there is a steady decline reflecting a downward trend of approximately 0.2–0.5% annually. This signifies a continuous improvement in healthcare and possibly the effectiveness of interventions and awareness programs. In 2023, the actual death rate for liver malignant neoplasms was 19.0. The data suggests a consistent reduction in mortality over the five-year period with a compound annual growth rate (CAGR) also indicating a slight annual decrease.
Future trends to watch include advancements in medical technology, improved early detection methods, and more comprehensive public health policies that could further impact these rates. Monitoring these factors will be crucial to understanding the trajectory of liver cancer mortality rates in Japan.
